Literature DB >> 16825143

Rheumatic fever-mimicking carditis as a first presentation of chronic active Epstein-Barr virus infection.

Taikai Toubo1, Shouichi Ohga, Hidetoshi Takada, Naohiro Suga, Akihiko Nomura, Takurou Ohno, Toshiro Hara.   

Abstract

UNLABELLED: A 7-y-old girl presented with prolonged fever, arrhythmia and cardiomegaly during the treatment course of group A beta-haemolytic streptococcal pharyngitis. The isolated rheumatogenic strain M1 suggested the diagnosis of rheumatic fever. However, serous pericardial effusion contained high levels of Epstein-Barr virus (EBV) DNA. Clonally proliferating EBV+ T cells were determined in the circulation. The atypical carditis without valvitis was then complicated by coronary artery dilatations. Four months after the start of prednisolone plus antiviral/bacterial therapy, EBV+ T-cell lymphoma developed in the thigh.
CONCLUSION: Atypical carditis may be a notable and life-threatening presentation of chronic active EBV infection to be differentiated from rheumatic fever.

Entities:  

Mesh:

Year:  2006        PMID: 16825143     DOI: 10.1080/08035250500371821

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  Cardiovascular complications associated with chronic active Epstein-Barr virus infection.

Authors:  Jun Muneuchi; Shouichi Ohga; Masataka Ishimura; Kazuyuki Ikeda; Kenichiro Yamaguchi; Akihiko Nomura; Hidetoshi Takada; Yasunobu Abe; Toshiro Hara
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

Review 2.  Early diagnosis and follow-up of chronic active Epstein-Barr-virus-associated cardiovascular complications with cardiovascular magnetic resonance imaging: A case report.

Authors:  Shu Jiang; Xiao Li; Jian Cao; Di Wu; Lingyan Kong; Lu Lin; Zhengyu Jin; Jing An; Yining Wang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.

Authors:  Haijuan Xiao; Bing Hu; Rongmu Luo; Huili Hu; Junmei Zhang; Weiying Kuang; Rui Zhang; Li Li; Gang Liu
Journal:  Virol J       Date:  2020-10-29       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.